Comparison of intravascular ultrasonic imaging with versus without incomplete stent apposition at follow-up after drug-eluting stent implantation

International Journal of Cardiovascular Imaging

Volumn 24, Issue 2, 2008, Pages 133-139

  Qian, Juying ^a   Zhang, Feng ^a   Wu, Hongyi ^a   Fan, Bing ^a   Ge, Lei ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Drug eluting stent; Incomplete stent apposition; Intravascular ultrasound

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MALE;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 38349144702     PISSN: 15695794     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10554-007-9249-1     Document Type: Article

References (31)

1. Sousa JE, Costa MA, Abizaid AC et al (2001) Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 104:2007-2011
2. Serruys PW, Degertekin M, Tanabe K et al (2002) Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106:798-803
3. Moses JW, Leon MB, Popma JJ et al (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323
4. Sousa JE, Costa MA, Sousa AG et al (2003) Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 107:381-383
5. Colombo A, Drzewiecki J, Banning A et al (2003) Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108:788-794
6. Tanabe K, Serruys PW, Degertekin M et al (2004) Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: Comparison with bare metal stents by serial intravascular ultrasound analyses: Data from the randomized TAXUS-II trial. Circulation 109:196-200
7. Weissman NJ, Koglin J, Cox DA et al (2005) Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1201-1205
8. Zhang F, Ge J, Qian J et al (2007) Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 48: 303-311
9. Aoki J, Colombo A, Dudek D et al (2005) Peristent remodeling and neointimal suppression two years after polymer-based, paclitaxel-eluting stent implantation. Insights from serial intravascular ultrasound analysis in the TAXUS-II study. Circulation 112:3876-3883
10. Ako J, Morino Y, Honda Y et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation a serial intravascular ultrasound analysis. J Am Coll Cardiol 46(6):1002-1005
11. Hong MK, Mintz GS, Lee CW et al (2006) Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 113(3):414-419 Jan 24
12. Mintz GS, Weissman NJ, Dawkins K et al (2006) Frequency, predictors, and clinical outcomes of late-acquired incomplete stent apposition in patients treated with Taxus stents a volumetric intravascular ultrasound meta-analysis from the TAXUS IV, V, and VI trials (abstr). J Am Coll Cardiol 47(Suppl B):26B
13. Zhang F, Qian JY, Ge JB et al (2006) Late stent malapposition and marked positive vessel remodeling after sirolimus-eluting coronary stent implantation. Chin Med J 119(4):349-350
14. Shah VM, Mintz GS, Apple S et al (2002) Background incidence of late malapposition after bare-metal stent implantation. Circulation 106:1753-1755
15. Nakamura M, Kataoka T, Honda Y et al (2003) Late incomplete stent apposition and focal vessel expansion after bare metal stenting. Am J Cardiol 92:1217-1219
16. Hong MK, Mintz GS, Lee CW et al (2004) Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 109:881-886
17. Mintz GS, Nissen SE, Anderson WD et al (2001) American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37:1478-1492
18. Tanabe K, Serruys PW, Degertekin M et al (2005) Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation. 111(7):900-905
19. Degertekin M, Regar E, Tanabe K et al (2003) Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. Am J Cardiol 91(9):1046-1050
20. Degertekin M, Serruys PW, Tanabe K et al (2003) Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 108:2747-2750
21. Zhang F, Qian JY, Ge JB (2007) Rapid development of late stent malappositon and coronary aneurysm following implantation of a paclitaxel-eluting coronary stent. Chin Med J 120:614-616
22. McFadden EP, Stabile E, Regar E et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet 364:1519-1521
23. Virmani R, Guagliumi G, Farb A et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701-705
24. Ong AT, Hoye A, Aoki J et al (2005) Thirty day incidence and six-month clinical outcome of thrombotic stent occlusion after bare metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45:947-953
25. Iakovou I, Schmidt T, Bonizzoni E et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126-2130
26. Acar G, Dogan A, Altinbas A et al (2006) Recurrent acute stent thrombosis associated with protein C and S deficiencies. Int J Cardiovasc Imaging 22:333-337
27. Breuckmann F, Nassenstein K, Boese D et al (2006) Successful nitinol stent implantation in a large coronary aneurysm: Post-interventional patency assessment by magnetic resonance imaging. Int J Cardiovasc Imaging 22:501-505
28. Takano M, Mizuno K (2006) Late coronary thrombosis in a sirolimus-eluting stent due to the lack of neointimal coverage. Eur Heart J 27:1133
29. Henderson D, Gunalingam B (2006) Very late stent thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv 68:406-408
30. Makaryus AN, Lefkowitz L, Lee AD (2007) Coronary artery stent fracture. Int J Cardiovasc Imaging 23:305-309
31. Kuchulakanti PK, Chu WW, Torguson R et al (2006) Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113:1108-1113